Ironwood Pharmaceuticals Inc (IRWD) Q4 2019 Earnings Call Transcript
IRWD earnings call for the period ending December 31, 2019.
Ironwood Pharmaceuticals
IRWD
IRWD
$12.06
-$1.01
-7.7%
Price as of February 14, 2020, 4:30 p.m. EST
View Interactive IRWD Charts
Ironwood Pharmaceuticals Inc. is an entrepreneurial pharmaceutical company that discovers develops and intends to commercialize differentiated medicines that improve patients’ lives.
News & Analysis: Ironwood Pharmaceuticals
Is Ironwood Pharmaceuticals Stock a Buy?
The stock is down year to date, but a strong fourth-quarter performance could quickly turn things around.
Ironwood Pharmaceuticals Inc (IRWD) Q3 2019 Earnings Call Transcript
IRWD earnings call for the period ending September 30, 2019.
Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know
The drugmaker delivered its first-ever quarterly profit and trounced Wall Street top- and bottom-line estimates.
Ironwood Pharmaceuticals Inc (IRWD) Q2 2019 Earnings Call Transcript
IRWD earnings call for the period ending June 30, 2019.
Here's Why Ironwood Pharmaceuticals Rose as Much as 12% Today
An SEC filing shows an activist investor is building a sizable position in the company.
Ironwood Pharmaceuticals Inc (IRWD) Q1 2019 Earnings Call Transcript
IRWD earnings call for the period ending March 31, 2019.
Why Ironwood's Shares Climbed 11.7% on Wednesday
The constipation kingpin reported fourth-quarter results that sparked investor interest.
Ironwood Pharmaceuticals Inc (IRWD) Q4 2018 Earnings Conference Call Transcript
IRWD earnings call for the period ending December 31, 2018.
Novartis May Beat Ironwood Pharmaceuticals to the Punch
Novartis may be on track to win FDA approval of a sickle disease drug before Ironwood.
